BMS-201620
BMS-201620 is a selective β3 full agonist, with a Ki of 93 nM. BMS-201620 can be used in the research of obesity and non-insulin-dependent diabetes[1].
Product Specifications
CAS Number
197643-49-5
UNSPSC
12352005
Target
Adrenergic Receptor
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Metabolic Disease
Smiles
C[C@@](C1=CC=C(OC)C=C1)(NC[C@H](O)C2=CC=C(O)C(NS(=O)(C)=O)=C2)C(NC3=CC=C(CP(OCC)(OCC)=O)C=C3)=O
Molecular Formula
C30H40N3O9PS
Molecular Weight
649.69
References & Citations
[1]Washburn WN, et al. BMS-201620: a selective beta 3 agonist. Bioorg Med Chem Lett. 2004 Jul 5;14 (13) :3525-9.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
β adrenergic receptor
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC470225-100 1x 100 µL
Major Vault Protein (MVP) (1032), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740745-100 1x 100 µL
CD45 / LCA (2B11 + PD7/26), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
